Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis

被引:93
作者
Maulik, N [1 ]
Kagan, VE
Tyurin, VA
Das, DK
机构
[1] Univ Connecticut, Sch Med, Mol Cardiol Lab, Cardiovasc Div,Dept Surg, Farmington, CT 06030 USA
[2] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15238 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1998年 / 274卷 / 01期
关键词
deoxyribonucleic acid fragmentation; phosphatidylserine and phosphatidylethanolamine translocation; ischemia-reperfusion;
D O I
10.1152/ajpheart.1998.274.1.H242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although cardiomyocyte death and infarction associated with ischemia-reperfusion are traditionally believed to be induced via necrosis, recent studies implicated apoptotic cell death in ischemic reperfused tissue. To examine whether myocardial ischemic reperfusion injury is mediated by apoptotic cell death, isolated perfused rat hearts were subjected to 15 and 30 min of ischemia as well as 15 min of ischemia followed by 30, 90, or 120 min of reperfusion. At the end of each experiment, hearts were processed for the evaluation of apoptosis and DNA laddering. Apoptosis was studied by visualizing the apoptotic cardiomyocytes by direct fluorescence detection of digoxigenin-labeled genomic DNA using APOPTAG in situ apoptosis detection kit. DNA laddering was evaluated by subjecting the DNA obtained from cardiomyocytes to 1.8% agarose gel electrophoresis and photographed under ultraviolet illumination. In addition, high-performance thin-layer chromatography (HPTLC) of aminophospholipids labeled with 2,4,6-trinitrobenzenesulfonate was performed to evaluate phospholipid topography in cardiomyocytes. The results of our study revealed apoptotic cells only in the 90- and 120-min reperfused hearts as demonstrated by the intense fluorescence of the immunostained digoxigenin-labeled genomic DNA when observed under fluorescence microscope. None of the ischemic hearts showed any evidence of apoptosis. These results corroborated with the findings of DNA fragmentation that showed increased ladders of DNA bands in the 120-min reperfused hearts, representing integer multiples of the internucleosomal DNA length (similar to 180 bp). Two-dimensional HPTLC of the phospholipids obtained from the cardiomyocytes and transbilayer organization of the phosphatidylethanolamine (PE) and phosphatidylserine (PS) in the myocytes indicated translocation of both PE and PS from the inner leaflet to the outer leaflet of the membrane as early as after 20 min of ischemia. These results demonstrate that the redistribution of PS and PE precedes the apototic cell death and DNA fragmentation associated with the reperfusion of ischemic myocardium, suggesting that ischemia may trigger the signal for apoptosis although it becomes evident during reperfusion.
引用
收藏
页码:H242 / H248
页数:7
相关论文
共 41 条
[1]   BINDING AND PHAGOCYTOSIS OF APOPTOTIC VASCULAR SMOOTH-MUSCLE CELLS IS MEDIATED IN PART BY EXPOSURE OF PHOSPHATIDYLSERINE [J].
BENNETT, MR ;
GIBSON, DF ;
SCHWARTZ, SM ;
TAIT, JF .
CIRCULATION RESEARCH, 1995, 77 (06) :1136-1142
[2]   MAINTENANCE OF LIPID ASYMMETRY IN RED-BLOOD-CELLS AND GHOSTS - EFFECT OF DIVALENT-CATIONS AND SERUM-ALBUMIN ON THE TRANSBILAYER DISTRIBUTION OF PHOSPHATIDYLSERINE [J].
CONNOR, J ;
GILLUM, K ;
SCHROIT, AJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1025 (01) :82-86
[3]   IMPROVEMENT OF ISCHEMIA-REPERFUSION-INDUCED MYOCARDIAL DYSFUNCTION BY MODULATING CALCIUM-OVERLOAD USING A NOVEL, SPECIFIC CALMODULIN ANTAGONIST, CGS-9343B [J].
DAS, DK ;
ENGELMAN, RM ;
PRASAD, MR ;
ROUSOU, JA ;
BREYER, RH ;
JONES, R ;
YOUNG, H ;
CORDIS, GA .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (03) :465-471
[4]  
DAS DK, 1994, METHOD ENZYMOL, V233, P601
[5]  
DAS DK, 1992, PATHOPHYSIOLOGY REPE, P149
[6]   Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis [J].
Fabisiak, JP ;
Kagan, VE ;
Ritov, VB ;
Johnson, DE ;
Lazo, JS .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1997, 272 (02) :C675-C684
[7]  
FADOK VA, 1993, J IMMUNOL, V151, P4274
[8]  
FADOK VA, 1992, J IMMUNOL, V148, P2207
[9]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[10]  
FUKUDA K, 1993, AM J PATHOL, V142, P935